With the new operations site and logistics center in Sydney, “Australian researchers and biotech companies will no longer need to navigate the complexities of permit applications, customs clearance, and tax payments, streamlining the procurement process, and allowing them to focus on advancing their groundbreaking research and innovation,” the company said.
Dawn Furnas is a writer for NJBIZ, focusing on local news and developments in New Jersey. With a keen interest in business, healthcare, and education, Dawn covers a wide range of topics, including mergers and acquisitions, executive appointments, and advancements in various industries within the state.